Literature DB >> 16763995

Amphetamine-induced hyperlocomotion in rats: Hippocampal modulation of the nucleus accumbens.

Ilsun M White1, Christopher Whitaker, Wesley White.   

Abstract

Using lesions and infusions, the present study investigated the way in which and the extent to which the ventral hippocampus (vHIP) modulates amphetamine-induced hyperactivity in rats. Rats were lesioned (excitotoxic or sham) in the vHIP or were implanted with cannulae for subsequent infusions. A high dose (12.5 microg/microl) of N-methyl-D-aspartate (NMDA) was used to make excitotoxic lesions and a low dose (0.5 microg/microl) of NMDA to cause activation of the hippocampus. Lidocaine was used to inactivate the hippocampus. Lidocaine or a low dose of NMDA was infused into the vHIP in combination with either systemic injection or intra-accumbens infusions of amphetamine. The effects of these treatments on locomotor activity were measured by distance traveled in 10-min intervals for 40-60 min. Lesions and deactivation of the hippocampus attenuated amphetamine-induced hyperlocomotion, compared to the controls. Stimulation of the hippocampus augmented amphetamine-induced hyperlocomotion. The present findings provide evidence that the hippocampus exerts excitatory modulation on the expression of behavioral excitation produced by amphetamine, likely via the nucleus accumbens. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763995     DOI: 10.1002/hipo.20189

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  12 in total

1.  Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease.

Authors:  Mark E Bardgett; Natasha N Davis; Patrick J Schultheis; Molly S Griffith
Journal:  Neurobiol Learn Mem       Date:  2010-11-10       Impact factor: 2.877

2.  Aversive stimuli alter ventral tegmental area dopamine neuron activity via a common action in the ventral hippocampus.

Authors:  Ornella Valenti; Daniel J Lodge; Anthony A Grace
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

Review 3.  Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Trends Pharmacol Sci       Date:  2011-06-21       Impact factor: 14.819

4.  Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition.

Authors:  Ahmed I Gilani; Muhammad O Chohan; Melis Inan; Scott A Schobel; Nashid H Chaudhury; Samuel Paskewitz; Nao Chuhma; Sara Glickstein; Robert J Merker; Qing Xu; Scott A Small; Stewart A Anderson; Margaret Elizabeth Ross; Holly Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-02       Impact factor: 11.205

5.  The Nucleus Reuniens of the Midline Thalamus Gates Prefrontal-Hippocampal Modulation of Ventral Tegmental Area Dopamine Neuron Activity.

Authors:  Eric C Zimmerman; Anthony A Grace
Journal:  J Neurosci       Date:  2016-08-24       Impact factor: 6.167

6.  Therapeutic Effects of Quetiapine and 5-HT1A Receptor Agonism on Hyperactivity in Dopamine-Deficient Mice.

Authors:  Yukiko Ochiai; Masayo Fujita; Yoko Hagino; Kazuto Kobayashi; Ryoichi Okiyama; Kazushi Takahashi; Kazutaka Ikeda
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

7.  Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: a mechanism of behavioral sensitization.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

8.  Memory and psychostimulants: modulation of Pavlovian fear conditioning by amphetamine in C57BL/6 mice.

Authors:  Suzanne C Wood; Stephan G Anagnostaras
Journal:  Psychopharmacology (Berl)       Date:  2008-05-15       Impact factor: 4.530

9.  A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia.

Authors:  A Shah; D J Lodge
Journal:  Transl Psychiatry       Date:  2013-01-15       Impact factor: 6.222

Review 10.  Dopamine System Dysregulation in Major Depressive Disorders.

Authors:  Pauline Belujon; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2017-12-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.